Detalhe da pesquisa
1.
Implementing Multilevel Network Meta-Regression for Time-To-Event Outcomes: A Case Study in Relapsed Refractory Multiple Myeloma.
Value Health
; 2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38679290
2.
Pembrolizumab plus chemotherapy for first-line treatment of advanced triple-negative breast cancer.
Future Oncol
; 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38597713
3.
Matching-Adjusted Indirect Comparison of Brexucabtagene Autoleucel (ZUMA-2) and Pirtobrutinib (BRUIN) in Patients with Relapsed/Refractory Mantle Cell Lymphoma Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor.
Adv Ther
; 41(5): 1938-1952, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38494543
4.
Correlation Between Early Time-to-Event Outcomes and Overall Survival in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Receiving Definitive Chemoradiation Therapy: Systematic Review and Meta-Analysis.
Front Oncol
; 12: 868490, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35574411
5.
Quantitative phase measurements of tendon collagen fibres.
J Biophotonics
; 10(1): 111-117, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26824333